Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).

Clinical trial NCT06799351 · RECRUITING

Trial details

NCT number: NCT06799351
Sponsor: Bernardino Clavo, MD, PhD
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Chemotherapy Induced Peripheral Neuropathy (CIPN)Paresthesia Numbness Tingling

Start date: 2025-02-07
Primary completion: 2029-12-31
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.